New York State Governor Andrew M. Cuomo recently announced the appointment of SUNY Upstate Medical University’s Stephen Thomas, MD, as lead principal investigator for the world-wide Pfizer/BioNTech vaccine trial, which recently revealed enormous potential with over 90 percent efficacy in preventing COVID-19. SUNY Upstate serves as one of the trial site organizations for the Phase 3, worldwide clinical trial. Dr. Thomas serves as Upstate’s Chief of Infectious Disease and supports Pfizer and BioNTech as they prepare vaccine trial data for submission to regulatory agencies including the U.S. Food and Drug Administration (FDA). TrialSite congratulates Dr. Stephen Thomas.
A Notable Role
An important role, Governor Cuomo declared New York’s medical experts are second to none and from the very beginning of this pandemic, we have relied on their vast knowledge and expertise to inform our response. I’m glad Pfizer is doing the same.” The Gov. continued, “It’s great news that Pfizer/BioNTech is seeing positive results from its vaccine trial, and I’m proud one of New York’s foremost infectious disease experts have been selected to lead its worldwide vaccine trial. On behalf of the fami...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).